Literature DB >> 22487801

New advances in juvenile spondyloarthritis.

Shirley M L Tse1, Ronald M Laxer.   

Abstract

Juvenile spondyloarthritis (SpA) is a distinct disease to adult SpA, and usually manifests as peripheral arthritis and enthesitis. Importantly, many patients with juvenile SpA continue to be at risk of developing ankylosing spondylitis during their disease course. In this Review, the classification and diagnostic criteria, clinical manifestations and treatment guidelines for juvenile SpA will be discussed. Advances in the diagnosis of and management strategies for juvenile SpA will lead to earlier recognition, appropriate treatment and improved rates of inactive disease, which should lead to improved patient outcomes and quality of life.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22487801     DOI： 10.1038/nrrheum.2012.37

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


  80 in total

1.  A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies.

Authors:  R Burgos-Vargas; J Vázquez-Mellado; C Pacheco-Tena; A Hernández-Garduño; M V Goycochea-Robles
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

2.  Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group.

Authors:  M A van Rossum; T J Fiselier; M J Franssen; A H Zwinderman; R ten Cate; L W van Suijlekom-Smit; W H van Luijk; R M van Soesbergen; N M Wulffraat; J C Oostveen; W Kuis; P F Dijkstra; C F van Ede; B A Dijkmans
Journal:  Arthritis Rheum       Date:  1998-05

3.  Use of contrast-enhanced MR imaging to detect sacroiliitis in children.

Authors:  M Bollow; J Braun; T Biedermann; S Mutze; S Paris; C Schauer-Petrowskaja; K Minden; S A Schmitz; M Schöntube; B Hamm
Journal:  Skeletal Radiol       Date:  1998-11       Impact factor: 2.199

4.  Preliminary definition of improvement in juvenile arthritis.

Authors:  E H Giannini; N Ruperto; A Ravelli; D J Lovell; D T Felson; A Martini
Journal:  Arthritis Rheum       Date:  1997-07

5.  Efficacy and safety of TNFalpha antagonist therapy in patients with juvenile spondyloarthropathies.

Authors:  Moana Sulpice; Chantal Job Deslandre; Pierre Quartier
Journal:  Joint Bone Spine       Date:  2008-12-12       Impact factor: 4.929

6.  A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.

Authors:  Nicolino Ruperto; Kevin J Murray; Valeria Gerloni; Nico Wulffraat; Sheila Knupp Feitosa de Oliveira; Fernanda Falcini; Pavla Dolezalova; Maria Alessio; Ruben Burgos-Vargas; Fabrizia Corona; Richard Vesely; Helen Foster; Joyce Davidson; Francesco Zulian; Line Asplin; Eileen Baildam; Julia Garcia Consuegra; Huri Ozdogan; Rotraud Saurenmann; Rik Joos; Angela Pistorio; Pat Woo; Alberto Martini
Journal:  Arthritis Rheum       Date:  2004-07

7.  [Juvenile spondarthritis. Retrospective study of 71 patients].

Authors:  R Häfner
Journal:  Monatsschr Kinderheilkd       Date:  1987-01       Impact factor: 0.323

8.  The early clinical recognition of juvenile-onset ankylosing spondylitis and its differentiation from juvenile rheumatoid arthritis.

Authors:  R Burgos-Vargas; J Vázquez-Mellado
Journal:  Arthritis Rheum       Date:  1995-06

9.  Infliximab in two patients with juvenile ankylosing spondylitis.

Authors:  Heinrike Schmeling; Gerd Horneff
Journal:  Rheumatol Int       Date:  2003-11-29       Impact factor: 2.631

10.  2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis.

Authors:  J Braun; R van den Berg; X Baraliakos; H Boehm; R Burgos-Vargas; E Collantes-Estevez; H Dagfinrud; B Dijkmans; M Dougados; P Emery; P Geher; M Hammoudeh; R D Inman; M Jongkees; M A Khan; U Kiltz; Tk Kvien; M Leirisalo-Repo; W P Maksymowych; I Olivieri; K Pavelka; J Sieper; E Stanislawska-Biernat; D Wendling; S Ozgocmen; C van Drogen; Bj van Royen; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2011-06       Impact factor: 19.103
View more
  28 in total

1.  Prominent midfoot involvement in children with enthesitis-related arthritis category of juvenile idiopathic arthritis.

Authors:  Sanat Phatak; Namita Mohindra; Abhishek Zanwar; Amita Aggarwal
Journal:  Clin Rheumatol       Date:  2017-06-20       Impact factor: 2.980

Review 2.  [Imaging options in pediatric rheumatology].

Authors:  D Windschall
Journal:  Z Rheumatol       Date:  2016-12       Impact factor: 1.372

Review 3.  Juvenile Spondyloarthropathies.

Authors:  Amra Adrovic; Kenan Barut; Sezgin Sahin; Ozgur Kasapcopur
Journal:  Curr Rheumatol Rep       Date:  2016-08       Impact factor: 4.592

Review 4.  Whole-body MRI of juvenile spondyloarthritis: protocols and pictorial review of characteristic patterns.

Authors:  Michael R Aquino; Shirley M L Tse; Sumeet Gupta; Alisa C Rachlis; Jennifer Stimec
Journal:  Pediatr Radiol       Date:  2015-04-21

5.  Differential pattern of Doppler signals at lower-extremity entheses of healthy children.

Authors:  Johannes Roth; Sara E Stinson; Jason Chan; Nick Barrowman; Luca Di Geso
Journal:  Pediatr Radiol       Date:  2019-07-09

Review 6.  Gut inflammation and microbiome in spondyloarthritis.

Authors:  Jayakanthan Kabeerdoss; Pulukool Sandhya; Debashish Danda
Journal:  Rheumatol Int       Date:  2015-12-30       Impact factor: 2.631

Review 7.  Developments in therapies for spondyloarthritis.

Authors:  Joachim Sieper
Journal:  Nat Rev Rheumatol       Date:  2012-04-10       Impact factor: 20.543

8.  Normal subchondral high T2 signal on MRI mimicking sacroiliitis in children: frequency, age distribution, and relationship to skeletal maturity.

Authors:  Nele Herregods; Lennart B O Jans; Min Chen; Joel Paschke; Stefanie L De Buyser; Thomas Renson; Joke Dehoorne; Rik Joos; Robert G W Lambert; Jacob L Jaremko
Journal:  Eur Radiol       Date:  2020-10-29       Impact factor: 5.315

Review 9.  Juvenile Spondyloarthritis: What More Do We Know About HLA-B27, Enthesitis, and New Bone Formation?

Authors:  Shi Huan Tay; Joo Guan Yeo; Jing Yao Leong; Salvatore Albani; Thaschawee Arkachaisri
Journal:  Front Med (Lausanne)       Date:  2021-05-20

10.  The performance of classification criteria for juvenile spondyloarthropathies.

Authors:  Amra Adrovic; Metin Sezen; Kenan Barut; Sezgin Sahin; Cengizhan Acikel; Erkan Demirkaya; Ozgur Kasapcopur
Journal:  Rheumatol Int       Date:  2017-10-10       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.